フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
BW20021113002206 20021113T140944Z UTC ( BW)(ELI-LILLY-&-CO)(BC43) Rebecca O. Kendall Announces Retirement; Robert A. Armitage Promoted to Lilly...
BW20021109002005 20021109T093011Z UTC ( BW)(ELI-LILLY-&-CO)(BC43) Eli Lilly and Company: Head-to-Head Study Showed Teriparatide -- rDNA origin...
BW20021108002093 20021108T123009Z UTC ( BW)(ELI-LILLY-&-CO)(BC43) Lilly Outlines to Wall Street Its Strategy To Realize Its Growth Opportunities...
BW20021107002583 20021108T071938Z UTC ( BW)(ELI-LILLY-&-CO)(BC43) Eli Lilly and Company: Postmenopausal Women Taking Lilly's Evista Show Strong...
BW20021107002438 20021107T180746Z UTC ( BW)(ELI-LILLY-&-CO)(BC43) Eli Lilly and Company: Postmenopausal Women Taking Lilly's Evista Show Strong...
BW20021105002447 20021105T160224Z UTC ( BW)(ELI-LILLY-&-CO)(BC43) Eli Lilly and Company: Xigris Sustains Survival Long Term in Severe Sepsis...
BW20021101002143 20021101T134705Z UTC ( BW)(ELI-LILLY-&-CO)(BC43) Eli Lilly and Company: Once-Daily Administration of Atomoxetine Reduced ADHD...
BW20021030002296 20021030T150313Z UTC ( BW)(ELI-LILLY-&-CO)(BC43) Eli Lilly and Company: Results Show Earlier Care Could Reduce Health Care Costs...
BW20021029000375 20021029T140010Z UTC ( BW)(ELI-LILLY-&-CO)(BC43) Cymbalta Data Suggest Rapid and Sustained Response by First Week of Therapy...
BW20021023002183 20021023T110936Z UTC ( BW)(ELI-LILLY-&-CO)(BC43) 3rd Quarter Results Business Editors UK REGULATORY NEWS INDIANAPOLIS--(BUSINESS...
BW20021021002870 20021022T060114Z UTC ( BW)(ELI-LILLY-&-CO)(BC43) Alimta Continues To Show Versatility in Treating Different Cancers Business...
BW20021021002691 20021021T191458Z UTC ( BW)(ELI-LILLY-&-CO)(BC43) Dividend Declaration Business Editors UK REGULATORY NEWS...
BW20021017002700 20021018T060036Z UTC ( BW)(ELI-LILLY-&-CO)(BC43) Combining Innovative Therapies for Optimal Cancer Care; Effectiveness of...
BW20021001002239 20021001T131010Z UTC ( BW)(ELI-LILLY-&-CO)(BC43) Newly Published Study Demonstrates Sustained Efficacy of Evista -raloxifene...
BW20020925002525 20020925T205917Z UTC ( BW)(ELI-LILLY-&-CO)(BC43) Lilly Asserts The New England Journal of Medicine ``Sounding Board'' Opinion...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約